Legal Issues | Asia Healthcare Blog

Exploring the Intersection of Business, Policy and Culture, in the Asian Healthcare Space

Lin v. Siemens AG could be a sign of things to come for China FCPA enforcement

Last week Reuters reported that a Siemens AG ex-compliance executive is suing the company on the grounds of firing him for exposing an anti-kickback scheme. The case was filed in the Southern District of New York and can be f...

by Damjan Denoble

Full Story »

Executing Joint Ventures for Healthcare Companies in China

Running in concert with this week’s JP Morgan Healthcare Conference is the OneMed China Forum III. You can find previous coverage of the 2012 event here, and a pre-amble to this year’s event here. Between last year and ...

by Benjamin

Full Story »

Rx for fraud: Health care fraud issues

In this column, we are featuring the work of Al Scott, a Principal at NSD Biogroup and an expert in biotechnology in China. The below article ran in the November/December 2012 edition of Fraud Magazine, a publication of the A...

by Al Scott

Full Story »

Why China’s Compulsory Licensing Might Not Be That Bad

Previously over at CNBC, in a past weekly column at Asia Times, and here at AHCB, I have written about the compulsory licensing regime China has adopted. Given India’s March 2012 compulsory license of Bayer’s Nexavar, man...

by Benjamin

Full Story »

Due Diligence for Senior Housing Operators in China

As North American senior care operators expand into China, one of the first decisions they will make – who to select as their real estate partner – is also likely to be one of the most critical. This would always be a piv...

by Benjamin

Full Story »